Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Fast stimulated Raman and second harmonic generation imaging for intraoperative gastro-intestinal cancer detection.

Sarri B, Canonge R, Audier X, Simon E, Wojak J, Caillol F, Cador C, Marguet D, Poizat F, Giovannini M, Rigneault H.

Sci Rep. 2019 Jul 11;9(1):10052. doi: 10.1038/s41598-019-46489-x.

PMID:
31296917
Free Article
2.

Agreement on endoscopic ultrasonography-guided tissue specimens: Comparing a 20-G fine-needle biopsy to a 25-G fine-needle aspiration needle among academic and non-academic pathologists.

van Riet PA, Cahen DL, Biermann K, Larghi A, Rindi G, Fellegara G, Arcidiacono P, Doglioni C, Liberta Decarli N, Iglesias-Garcia J, Abdulkader I, Lazare Iglesias H, Kitano M, Chikugo T, Yasukawa S, van der Valk H, Nguyen NQ, Ruszkiewicz A, Giovannini M, Poizat F, van der Merwe S, Santo E, Chang K, Lin F, Farrell J, Robert M, Bucobo JC, Heimann A, Baldaque-Silva F, Bruno MJ.

Dig Endosc. 2019 Jul 10. doi: 10.1111/den.13424. [Epub ahead of print]

PMID:
31290176
3.

International Study Group of Pancreatic Surgery type 3 and 4 venous resections in patients with pancreatic adenocarcinoma:the Paoli-Calmettes Institute experience.

Al Faraï A, Garnier J, Ewald J, Marchese U, Gilabert M, Moureau-Zabotto L, Poizat F, Giovannini M, Delpero JR, Turrini O.

Eur J Surg Oncol. 2019 Jun 3. pii: S0748-7983(19)30494-9. doi: 10.1016/j.ejso.2019.06.003. [Epub ahead of print]

PMID:
31186204
4.

Effect of clinical status on survival in patients with borderline or locally advanced pancreatic adenocarcinoma.

Duconseil P, Garnier J, Weets V, Ewald J, Marchese U, Gilabert M, Moureau-Zabotto L, Poizat F, Giovannini M, Delpero JR, Turrini O.

World J Surg Oncol. 2019 Jun 4;17(1):95. doi: 10.1186/s12957-019-1637-1.

5.

National multicentric evaluation of quality of pathology reports for rectal cancer in France in 2016.

Boutanos C, Capdepont M, Svrcek M, Thélu F, Guedj N, Poizat F, Bibeau F, Turlin B, Rousseau A, Bardier A, Selves J, Desrousseaux M, Le Pessot F, Bonhomme B, Laverrière MH, Julié C, Eyremandi RP, Stanislas S, Bazille C, Daubech A, Lazure T, Bordier MS, Demoures A, Rullier A.

Virchows Arch. 2019 May;474(5):561-568. doi: 10.1007/s00428-019-02534-8. Epub 2019 Feb 6.

PMID:
30729335
6.

Patients with resectable pancreatic adenocarcinoma: A 15-years single tertiary cancer center study of laparotomy findings, treatments and outcomes.

Gilabert M, Turrini O, Ewald J, Moureau-Zabotto L, Poizat F, Raoul JL, Delpero JR.

Surg Oncol. 2018 Dec;27(4):619-624. doi: 10.1016/j.suronc.2018.07.014. Epub 2018 Aug 3.

PMID:
30449481
7.

A multicenter randomized trial comparing a 25-gauge EUS fine-needle aspiration device with a 20-gauge EUS fine-needle biopsy device.

van Riet PA, Larghi A, Attili F, Rindi G, Nguyen NQ, Ruszkiewicz A, Kitano M, Chikugo T, Aslanian H, Farrell J, Robert M, Adeniran A, Van Der Merwe S, Roskams T, Chang K, Lin F, Lee JG, Arcidiacono PG, Petrone M, Doglioni C, Iglesias-Garcia J, Abdulkader I, Giovannini M, Bories E, Poizat F, Santo E, Scapa E, Marmor S, Bucobo JC, Buscaglia JM, Heimann A, Wu M, Baldaque-Silva F, Moro CF, Erler NS, Biermann K, Poley JW, Cahen DL, Bruno MJ.

Gastrointest Endosc. 2019 Feb;89(2):329-339. doi: 10.1016/j.gie.2018.10.026. Epub 2018 Oct 24.

PMID:
30367877
8.

Characterization of subepithelial lesions of the stomach and esophagus by contrast-enhanced EUS: A retrospective study.

Pesenti C, Bories E, Caillol F, Ratone JP, Godat S, Monges G, Poizat F, Raoul JL, Ries P, Giovannini M.

Endosc Ultrasound. 2019 Jan-Feb;8(1):43-49. doi: 10.4103/eus.eus_89_17.

9.

Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts.

Nicolle R, Blum Y, Marisa L, Loncle C, Gayet O, Moutardier V, Turrini O, Giovannini M, Bian B, Bigonnet M, Rubis M, Elarouci N, Armenoult L, Ayadi M, Duconseil P, Gasmi M, Ouaissi M, Maignan A, Lomberk G, Boher JM, Ewald J, Bories E, Garnier J, Goncalves A, Poizat F, Raoul JL, Secq V, Garcia S, Grandval P, Barraud-Blanc M, Norguet E, Gilabert M, Delpero JR, Roques J, Calvo E, Guillaumond F, Vasseur S, Urrutia R, de Reyniès A, Dusetti N, Iovanna J.

Cell Rep. 2017 Nov 28;21(9):2458-2470. doi: 10.1016/j.celrep.2017.11.003.

10.

Prognostic Value of Resection Margin Involvement After Pancreaticoduodenectomy for Ductal Adenocarcinoma: Updates From a French Prospective Multicenter Study.

Delpero JR, Jeune F, Bachellier P, Regenet N, Le Treut YP, Paye F, Carrere N, Sauvanet A, Adham M, Autret A, Poizat F, Turrini O, Boher JM.

Ann Surg. 2017 Nov;266(5):787-796. doi: 10.1097/SLA.0000000000002432.

PMID:
28953554
11.

A 25-gene classifier predicts overall survival in resectable pancreatic cancer.

Birnbaum DJ, Finetti P, Lopresti A, Gilabert M, Poizat F, Raoul JL, Delpero JR, Moutardier V, Birnbaum D, Mamessier E, Bertucci F.

BMC Med. 2017 Sep 20;15(1):170. doi: 10.1186/s12916-017-0936-z.

12.

Impact of Full Spectrum Endoscopy® (Fuse®, EndoChoice®) on adenoma detection: a prospective French pilot study.

Ratone JP, Bories E, Caillol F, Pesenti C, Godat S, Sellier F, Hoibian S, Landon M, Servajean C, Cassan C, Lestelle V, Casanova JP, Poizat F, Giovannini M.

Ann Gastroenterol. 2017;30(5):512-517. doi: 10.20524/aog.2017.0176. Epub 2017 Jul 5.

13.

Probe confocal laser endomicroscopy in the therapeutic endoscopic management of Barrett's dysplasia.

Caillol F, Godat S, Poizat F, Auttret A, Pesenti C, Bories E, Ratone JP, Giovannini M.

Ann Gastroenterol. 2017;30(3):295-301. doi: 10.20524/aog.2017.0138. Epub 2017 Mar 24.

14.

Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs?

Mohamed A, Romano D, Saveanu A, Roche C, Albertelli M, Barbieri F, Brue T, Niccoli P, Delpero JR, Garcia S, Ferone D, Florio T, Moutardier V, Poizat F, Barlier A, Gerard C.

Oncotarget. 2017 Jun 20;8(25):41044-41063. doi: 10.18632/oncotarget.17008.

15.

Prognostic Value of Molecular Subtypes in Pancreatic Cancer.

Bertucci F, Birnbaum DJ, Finetti P, Gilabert M, Poizat F, Raoul JL, Birnbaum D, Mamessier E.

Pancreas. 2017 Apr;46(4):e29-e31. doi: 10.1097/MPA.0000000000000787. No abstract available.

PMID:
28291163
16.

Gene expression profiling of patient-derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine efforts.

Bian B, Bigonnet M, Gayet O, Loncle C, Maignan A, Gilabert M, Moutardier V, Garcia S, Turrini O, Delpero JR, Giovannini M, Grandval P, Gasmi M, Ouaissi M, Secq V, Poizat F, Nicolle R, Blum Y, Marisa L, Rubis M, Raoul JL, Bradner JE, Qi J, Lomberk G, Urrutia R, Saul A, Dusetti N, Iovanna J.

EMBO Mol Med. 2017 Apr;9(4):482-497. doi: 10.15252/emmm.201606975.

17.

Endotherapy in case of relapse of neoplastic Barrett's esophagus after successful initial endoscopic resection.

Godat S, Caillol F, Autret A, Bories E, Pesenti C, Ratone JP, De Cassan C, Poizat F, Giovannini M.

Surg Endosc. 2017 Sep;31(9):3703-3710. doi: 10.1007/s00464-016-5409-5. Epub 2017 Jan 11.

PMID:
28078459
18.

Oral steroid prophylaxis is effective in preventing esophageal strictures after large endoscopic resection.

Ratone JP, Bories E, Caillol F, Pesenti C, Godat S, Poizat F, Cassan C, Giovannini M.

Ann Gastroenterol. 2017;30(1):62-66. doi: 10.20524/aog.2016.0085. Epub 2016 Sep 6.

19.

Short- and Mid-Term Outcomes after Endoscopic Transanal or Laparoscopic Transabdominal Total Mesorectal Excision for Low Rectal Cancer: A Single Institutional Case-Control Study.

Lelong B, Meillat H, Zemmour C, Poizat F, Ewald J, Mege D, Lelong JC, Delpero JR, de Chaisemartin C.

J Am Coll Surg. 2017 May;224(5):917-925. doi: 10.1016/j.jamcollsurg.2016.12.019. Epub 2016 Dec 24.

PMID:
28024946
20.

Combined NOTES total mesorectal excision and single-incision laparoscopy principles for conservative proctectomy: a single-centre study.

Meillat H, de Chaisemartin C, Poizat F, Bories E, Fara R, Delpero JR, Lelong B.

Tech Coloproctol. 2017 Jan;21(1):43-51. doi: 10.1007/s10151-016-1568-6. Epub 2016 Dec 19.

PMID:
27990592
21.

Prognostic value of PDL1 expression in pancreatic cancer.

Birnbaum DJ, Finetti P, Lopresti A, Gilabert M, Poizat F, Turrini O, Raoul JL, Delpero JR, Moutardier V, Birnbaum D, Mamessier E, Bertucci F.

Oncotarget. 2016 Nov 1;7(44):71198-71210. doi: 10.18632/oncotarget.11685.

22.

Endoscopic ultrasound-guided needle-based confocal laser endomicroscopy in solid pancreatic masses.

Giovannini M, Caillol F, Monges G, Poizat F, Lemaistre AI, Pujol B, Lucidarme D, Palazzo L, Napoléon B.

Endoscopy. 2016 Oct;48(10):892-8. doi: 10.1055/s-0042-112573. Epub 2016 Aug 30.

PMID:
27576181
23.

A pancreatic ductal adenocarcinoma subpopulation is sensitive to FK866, an inhibitor of NAMPT.

Barraud M, Garnier J, Loncle C, Gayet O, Lequeue C, Vasseur S, Bian B, Duconseil P, Gilabert M, Bigonnet M, Maignan A, Moutardier V, Garcia S, Turrini O, Delpero JR, Giovannini M, Grandval P, Gasmi M, Ouaissi M, Secq V, Poizat F, Guibert N, Iovanna J, Dusetti N.

Oncotarget. 2016 Aug 16;7(33):53783-53796. doi: 10.18632/oncotarget.10776.

24.

Heterogeneity of metastatic pancreatic adenocarcinoma: Lung metastasis show better prognosis than liver metastasis-a case control study.

Decoster C, Gilabert M, Autret A, Turrini O, Oziel-Taieb S, Poizat F, Giovannini M, Viens P, Iovanna J, Raoul JL.

Oncotarget. 2016 Jul 19;7(29):45649-45655. doi: 10.18632/oncotarget.9861.

25.

Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity.

Pasero C, Gravis G, Guerin M, Granjeaud S, Thomassin-Piana J, Rocchi P, Paciencia-Gros M, Poizat F, Bentobji M, Azario-Cheillan F, Walz J, Salem N, Brunelle S, Moretta A, Olive D.

Cancer Res. 2016 Apr 15;76(8):2153-65. doi: 10.1158/0008-5472.CAN-15-1965. Epub 2016 Apr 5.

26.

Neoplastic Barrett's oesophagus and long-term follow-up after endoscopic therapy: complete histological eradication of Barrett associated with high-grade dysplasia significantly decreases neoplasia relapse.

Caillol F, Godat S, Autret A, Bories E, Pesenti C, Ratone JP, Poizat F, Guiramand J, Delpero JR, Giovannini M.

Surg Endosc. 2016 Dec;30(12):5410-5418. Epub 2016 Apr 29.

PMID:
27129553
27.

Efficiency and safety of endoscopic resection in the management of subepithelial lesions of the stomach.

Godat S, Robert M, Caillol F, Bories E, Pesenti C, De Cassan C, Ratone JP, Poizat F, Giovannini M.

United European Gastroenterol J. 2016 Apr;4(2):250-6. doi: 10.1177/2050640615604774. Epub 2015 Sep 7.

28.

Isolated Splenic Metastases of Her2+++ Gastroesophageal Junction Adenocarcinoma.

Sigrand J, Bazin C, Ewald J, Dermeche S, Ries P, Poizat F, Guiramand J, Raoul JL.

Case Rep Oncol. 2016 Mar 9;9(1):154-7. doi: 10.1159/000444786. eCollection 2016 Jan-Apr.

29.

[A solid variant of a serous cystadenocarcinoma of the pancreas].

Brandone N, Poizat F, Thomassin-Piana J, Turrini O, Popovici C, Terris B.

Ann Pathol. 2016 Apr;36(2):125-9. doi: 10.1016/j.annpat.2015.12.004. Epub 2016 Mar 17. French.

PMID:
26995101
30.

Solid Pseudopapillary Tumor of the Pancreas: One Case with a Metastatic Evolution in a Caucasian Woman.

Lestelle V, de Coster C, Sarran A, Poizat F, Delpero JR, Raoul JL.

Case Rep Oncol. 2015 Oct 6;8(3):405-8. doi: 10.1159/000441022. eCollection 2015 Sep-Dec.

31.

In vivo characterization of pancreatic cystic lesions by needle-based confocal laser endomicroscopy (nCLE): proposition of a comprehensive nCLE classification confirmed by an external retrospective evaluation.

Napoleon B, Lemaistre AI, Pujol B, Caillol F, Lucidarme D, Bourdariat R, Morellon-Mialhe B, Fumex F, Lefort C, Lepilliez V, Palazzo L, Monges G, Poizat F, Giovannini M.

Surg Endosc. 2016 Jun;30(6):2603-12. doi: 10.1007/s00464-015-4510-5. Epub 2015 Oct 1.

PMID:
26428198
32.

Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer.

Lhoumeau AC, Martinez S, Boher JM, Monges G, Castellano R, Goubard A, Doremus M, Poizat F, Lelong B, de Chaisemartin C, Bardin F, Viens P, Raoul JL, Prebet T, Aurrand-Lions M, Borg JP, Gonçalves A.

PLoS One. 2015 May 11;10(5):e0123768. doi: 10.1371/journal.pone.0123768. eCollection 2015.

33.

Deciphering the cellular source of tumor relapse identifies CD44 as a major therapeutic target in pancreatic adenocarcinoma.

Molejon MI, Tellechea JI, Loncle C, Gayet O, Gilabert M, Duconseil P, Lopez-Millan MB, Moutardier V, Gasmi M, Garcia S, Turrini O, Ouaissi M, Poizat F, Dusetti N, Iovanna J.

Oncotarget. 2015 Apr 10;6(10):7408-23.

34.

Transcriptomic analysis predicts survival and sensitivity to anticancer drugs of patients with a pancreatic adenocarcinoma.

Duconseil P, Gilabert M, Gayet O, Loncle C, Moutardier V, Turrini O, Calvo E, Ewald J, Giovannini M, Gasmi M, Bories E, Barthet M, Ouaissi M, Goncalves A, Poizat F, Raoul JL, Secq V, Garcia S, Viens P, Iovanna J, Dusetti N.

Am J Pathol. 2015 Apr;185(4):1022-32. doi: 10.1016/j.ajpath.2014.11.029. Epub 2015 Mar 9.

PMID:
25765988
35.

Solid pancreatic tumors in patients younger than 40 years old--experience of a French comprehensive cancer center.

Gilabert M, Turrini O, Niccoli P, Moureau-Zabotto L, Boher JM, Poizat F, Giovannini M, Delpero JR, Raoul JL.

Pancreas. 2015 Mar;44(2):345-6. doi: 10.1097/MPA.0000000000000221. No abstract available.

PMID:
25675423
36.

Evaluation of pCLE in the bile duct: final results of EMID study : pCLE: impact in the management of bile duct strictures.

Caillol F, Bories E, Autret A, Poizat F, Pesenti C, Ewald J, Turrini O, Delpero JR, Monges G, Giovannini M.

Surg Endosc. 2015 Sep;29(9):2661-8. doi: 10.1007/s00464-014-3986-8. Epub 2014 Dec 10.

PMID:
25492449
37.

A subgroup of pancreatic adenocarcinoma is sensitive to the 5-aza-dC DNA methyltransferase inhibitor.

Gayet O, Loncle C, Duconseil P, Gilabert M, Lopez MB, Moutardier V, Turrini O, Calvo E, Ewald J, Giovannini M, Gasmi M, Bories E, Barthet M, Ouaissi M, Goncalves A, Poizat F, Raoul JL, Secq V, Garcia S, Viens P, Dusetti N, Iovanna J.

Oncotarget. 2015 Jan 20;6(2):746-54.

38.

Distant lymph node metastases in gastroesophageal junction adenocarcinoma: impact of endoscopic ultrasound-guided fine-needle aspiration.

Araujo J, Bories E, Caillol F, Pesenti C, Guiramand J, Poizat FF, Monges G, Ries P, Raoul JL, Delpero JR, Giovannini M.

Endosc Ultrasound. 2013 Jul;2(3):148-52. doi: 10.7178/eus.06.006.

39.

Radio(chemo)therapy in Elderly Patients with Esophageal Cancer: A Feasible Treatment with an Outcome Consistent with Younger Patients.

Rochigneux P, Resbeut M, Rousseau F, Bories E, Raoul JL, Poizat F, Moureau-Zabotto L.

Front Oncol. 2014 May 12;4:100. doi: 10.3389/fonc.2014.00100. eCollection 2014.

40.

Solid pancreatic lesions: The choice of fine-needle aspiration-needle to optimize the diagnosis.

Francioni E, Reimão S, Bories E, Caillol F, Pesenti C, Poizat F, Monges G, Giovannini M.

Endosc Ultrasound. 2014 Apr;3(Suppl 1):S12-3.

41.

[Peritoneal malignant mesothelioma: review and recent data].

Mery É, Hommell-Fontaine J, Capovilla M, Chevallier A, Bibeau F, Croce S, Dartigues P, Kaci R, Lang-Averous G, Laverriere MH, Leroux-Broussier A, Poizat F, Robin N, Valmary-Degano S, Verriele-Beurrier V, Villeneuve L, Isaac S.

Ann Pathol. 2014 Feb;34(1):26-33. doi: 10.1016/j.annpat.2014.01.004. Epub 2014 Feb 11. Review. French.

PMID:
24630634
42.

[Peritoneal pseudomyxoma: an overview emphasizing pathological assessment and therapeutic strategies].

Dartigues P, Isaac S, Villeneuve L, Glehen O, Capovilla M, Chevallier A, Croce S, Kaci R, Lang-Averous G, Laverriere MH, Leroux-Broussier A, Mery É, Poizat F, Valmary-Degano S, Verriele-Beurrier V, Gilly FN, Bibeau F.

Ann Pathol. 2014 Feb;34(1):14-25. doi: 10.1016/j.annpat.2014.01.012. Epub 2014 Feb 25. French.

PMID:
24630633
43.

[The RENAPE network: towards a new healthcare organization for the treatment of rare tumors of the peritoneum. Description of the network and role of the pathologists].

Villeneuve L, Isaac S, Glehen O, Capovilla M, Chevallier A, Croce S, Dartigues P, Fontaine J, Kaci R, Lang-Averous G, Laverriere MH, Leroux-Broussier A, Mery E, Poizat F, Valmary-Degano S, Verriele-Beurrier V, Gilly FN, Bibeau F.

Ann Pathol. 2014 Feb;34(1):4-8. doi: 10.1016/j.annpat.2014.01.008. Epub 2014 Feb 20. French.

PMID:
24630631
44.

[An uncommon spleen tumor].

Thomassin-Piana J, Delpero JR, Poizat F, Monges G.

Ann Pathol. 2013 Dec;33(6):422-4. doi: 10.1016/j.annpat.2013.10.018. Epub 2013 Nov 26. French. No abstract available.

PMID:
24331727
45.

Impact of radiotherapy in the management of locally advanced extrahepatic cholangiocarcinoma.

Moureau-Zabotto L, Turrini O, Resbeut M, Raoul JL, Giovannini M, Poizat F, Piana G, Delpero JR, Bertucci F.

BMC Cancer. 2013 Dec 3;13:568. doi: 10.1186/1471-2407-13-568.

46.

Can we resect EGC with Signet ring cells in Europe?

Caillol F, Bories E, Guiramand J, Pesenti C, Poizat F, Monges G, Giovannini M.

J Gastrointest Cancer. 2013 Dec;44(4):422-7. doi: 10.1007/s12029-013-9529-z.

PMID:
23912607
47.

Endomicroscopy in bile duct: Inflammation interferes with pCLE applied in the bile duct: A prospective study of 54 patients.

Caillol F, Bories E, Poizat F, Pesenti C, Esterni B, Monges G, Giovannini M.

United European Gastroenterol J. 2013 Apr;1(2):120-7. doi: 10.1177/2050640613483462.

48.

EGFR Expression and KRAS and BRAF Mutational Status in Intestinal-Type Sinonasal Adenocarcinoma.

Szablewski V, Solassol J, Poizat F, Larrieux M, Crampette L, Mange A, Bascoul-Mollevi C, Costes V.

Int J Mol Sci. 2013 Mar 4;14(3):5170-81. doi: 10.3390/ijms14035170.

49.

Pancreatic Adenocarcinoma with Early Intense Enhancement in Harmonic Contrast-Endoscopic Ultrasound and High Strain Ratio in Elastometry (with video).

Caillol F, Galasso D, Bories E, Pesenti C, Poizat F, Monges G, Giovannini M.

Endosc Ultrasound. 2013 Jan;2(1):41-2. doi: 10.7178/eus.04.008. No abstract available.

50.

A distinctive epitheliomesenchymal biphasic tumor in the duodenum: the first case of duodenoblastoma?

Poizat F, de Chaisemartin C, Bories E, Delpero JR, Xerri L, Flejou JF, Monges G.

Virchows Arch. 2012 Oct;461(4):379-83. doi: 10.1007/s00428-012-1307-y. Epub 2012 Sep 8.

PMID:
22961103

Supplemental Content

Loading ...
Support Center